What sets us apart is our experience-based understanding of
government, industry & patient challenges.
We effectively manage all aspects of Canadian market access,
from early global strategic planning to the design of Phase 4
data collection programs to facilitate or improve coverage.
We are experienced in a diversity of access
issues across a broad spectrum of therapeutic areas, such as
Oncology, Infectious Disease, Neurology, Dermatology,
Gastrointestinal, Endocrinology, Respiratory, Bone,
Cardiovascular, Biologics, Novel Delivery Systems, Rare Disease
Therapies, and many other highly specialized products.
We approach product coverage from the
payer perspective, and work to provide
our clients with consistent messaging and strategies. We
specialize in achieveing optimal coverage for new
pharmaceuticals, including specialty pharmaceuticals, biologics,
and genetically-based therapies.